Axcella Health Inc.
AXLADelisted Feb 15, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001633070
Axcella Health Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Mar 3, 2023; 15 institutions reported holding it in 13F filings for Q3 2023, worth $17.1M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Axcella Health Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 34 | 1 | 34 | +1 |
| Shares | 34.1M | 61.5K | 34.1M | +105.6K (+0.3%) |
| Value | $69.2M | $125.0K | $58.3M | −$10.7M (−15.5%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Axcella Health Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Thrivent Financial for Lutherans | 34,500 | $67.0K | 0.00% |
| Commonwealth Equity Services, LLC | 20,000 | $34.0K | 0.00% |
| Group One Trading, L.P. | 400 | $1.00K | 0.00% |
Sold out (2)
Institutions that held Axcella Health Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| HighTower Advisors, LLC | 11,000 | $22.0K |
| Captrust Financial Advisors | 4,000 | $8.00K |
Not filed for Q3 2022 yet (1)
Institutions that held Axcella Health Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Pinnacle Private Wealth, LLC | 61,500 | $125.0K |